Song Gao1, Taijun Yin2, Beibei Xu2, Yong Ma2, Ming Hu2. 1. Department of Pharmacological and Pharmaceutical Sciences, University of Houston, 1441 Moursund Street, Houston, TX 77030, USA. Electronic address: sgao3@uh.edu. 2. Department of Pharmacological and Pharmaceutical Sciences, University of Houston, 1441 Moursund Street, Houston, TX 77030, USA.
Abstract
AIM: Copper deficiency could cause fatal hematological and neurological disorders or other diseases. Amino acids are involved in the absorption of copper ions. The purpose of this study is to evaluate the absorption of copper in amino acid complex forms and determine its mechanism in the Caco-2 cell culture model. MAIN METHODS: The human colonic adenocarcinoma cell line Caco-2 culture model was used to determine the permeability of copper ions in inorganic form (CuSO4) and the amino acid complex forms. Lysine and methionine, as well as carboplatin were used to determine the possible involvement of amino acid transporters or copper transporter 1 (CTR1). KEY FINDINGS: The results showed that all of the amino acid complex forms facilitated copper absorption. The apparent permeabilities of copper ions in these complex forms were at least 7.6 fold higher than those in the CuSO4 form. The permeability rank order of copper in various amino acid complex forms was Cu-glutamate<Cu-lysine=Cu-aspartic acid=Cu methionine<Cu-arginine<Cu-(lysine/glutamate). Mechanistic studies revealed that the enhanced absorption of copper in copper amino acid complexes could be the result of enhanced uptake (as in Cu-methionine complex) or enhanced basolateral efflux (as in Cu-lysine complex). Copper transporter 1 (or CTR1) inhibitor carboplatin did not affect the absorption of copper in Cu-methionine complex, suggesting that the dominant pathway for copper amino acid complexes is not CTR1. SIGNIFICANCE: Enhanced absorption of copper ions in amino acid complex appears to be mediated by amino acid transporters.
AIM: Copper deficiency could cause fatal hematological and neurological disorders or other diseases. Amino acids are involved in the absorption of copper ions. The purpose of this study is to evaluate the absorption of copper in amino acid complex forms and determine its mechanism in the Caco-2 cell culture model. MAIN METHODS: The humancolonic adenocarcinoma cell line Caco-2 culture model was used to determine the permeability of copper ions in inorganic form (CuSO4) and the amino acid complex forms. Lysine and methionine, as well as carboplatin were used to determine the possible involvement of amino acid transporters or copper transporter 1 (CTR1). KEY FINDINGS: The results showed that all of the amino acid complex forms facilitated copper absorption. The apparent permeabilities of copper ions in these complex forms were at least 7.6 fold higher than those in the CuSO4 form. The permeability rank order of copper in various amino acid complex forms was Cu-glutamate<Cu-lysine=Cu-aspartic acid=Cumethionine<Cu-arginine<Cu-(lysine/glutamate). Mechanistic studies revealed that the enhanced absorption of copper in copper amino acid complexes could be the result of enhanced uptake (as in Cu-methionine complex) or enhanced basolateral efflux (as in Cu-lysine complex). Copper transporter 1 (or CTR1) inhibitor carboplatin did not affect the absorption of copper in Cu-methionine complex, suggesting that the dominant pathway for copper amino acid complexes is not CTR1. SIGNIFICANCE: Enhanced absorption of copper ions in amino acid complex appears to be mediated by amino acid transporters.
Authors: Ann Katrin Sauer; Stefanie Pfaender; Simone Hagmeyer; Laura Tarana; Ann-Kathrin Mattes; Franziska Briel; Sébastien Küry; Tobias M Boeckers; Andreas M Grabrucker Journal: Biometals Date: 2017-07-17 Impact factor: 2.949
Authors: Camilla Gomes Pereira; Carlos Boa-Viagem Rabello; Mércia Rodrigues Barros; Helena Emilia C C C Manso; Marcos Jose Batista Dos Santos; Andresa G Faria; Heraldo Bezerra de Oliveira; Waleska Rocha Leite Medeiros-Ventura; Rogerio Ventura Silva Júnior; Cleyton C D Carvalho; Alba K Fireman Journal: PLoS One Date: 2020-11-04 Impact factor: 3.240